Glycobiology · 2006 · 66 citations · 9 references
Life SciencesBiochemistryCell BiologyCell DifferentiationGlycobiologyStem Cell BiologyAntibody CharacterizationCarbohydrate StructureCell-surface GlycansDevelopmental GlycobiologyGlycan AnalysisGlycan StructureCarbohydrate Binding SpecificityHuman Embryonic Stem CellsLectin Binding SpecificityLectin-based Glycan AnalysisLectin-carbohydrate InteractionsLectin-carbohydrate RecognitionLectin-glycan Interactions In DevelopmentLectins
The carbohydrates present on the surface of differentiated human embryonic stem cells (hESCs) are not yet well established. Here, we have employed a panel of lectins and several anti-carbohydrate antibodies to determine the carbohydrates that are present at day 12 of hESC differentiation as embryoid bodies (EBs). On the basis of staining with fluorescein-labeled lectins, we have determined the presence of both terminal and internally linked alpha-d-mannopyranosyl groups, poly-N-acetyllactosaminyl chains, both alpha2,3- and alpha2,6-linked N-acetylneuraminic acid (Neu5Ac), alpha1,6-linked l-fucosyl, and beta-D-galactosyl groups, and more specifically, the T, Tn, and sialyl-Tn antigens. However, no alpha1,2-linked l-fucosyl, terminal nonreducing alpha-D-galactosyl, N-acetyl-beta-D-glucosaminyl, nor N-acetyl-alpha-D-galactosaminyl groups were found by this approach. We also established the presence of Neu5Acalpha2,3/2,6-Galbeta1,4 GlcNAc-terminated chains on the surfaces of 12-day-old EBs, as indicated by the great enhancement of staining by Erythrina cristagalli agglutinin (ECA) after treatment with neuraminidase. In each case, inhibition of binding by a haptenic sugar or treatment with neuraminidase was used to eliminate the possibility of nonspecific binding of the lectins. A comparison with undifferentiated cell staining revealed an increase in alpha2,3-linked Neu5Ac as well as a change to exclusively alpha1,6-linked l-fucose upon differentiation.
9
T and Tn, General Carcinoma Autoantigens
Georg F. Springer · Science · 1984 · 1K citations
Life Sciences, Immunology, Oncology +17
Reiji Kannagi, Nancy A. Cochran, Fumitsugu Ishigami et al. · The EMBO Journal · 1983 · 544 citations · Full text